|
Accueil > Actualité
Novo Nordisk: acquires Danish Embark Biotech
(CercleFinance.com) - Novo Nordisk will pursue its development in obesity treatment market with the acquisition of Danish company Embark Biotech, as it announced on Wednesday.
Under the terms of the deal, Novo will acquire the rights to develop and market Embark's lead candidate, an experimental treatment for obesity, for a cash consideration of E15m. The biotech's shareholders could also receive up to a further E456m in milestone payments, depending on the product's progress. Copyright (c) 2023 CercleFinance.com. All rights reserved. |
01/12/2023 17:22
Crédit Agricolel'UE approuve une co-acquisition en Italie 01/12/2023 17:22 Crédit Agricolel'UE approuve une acquisition en Italie 01/12/2023 17:03 Fermentalgla CDC détient moins de 15 % des votes 01/12/2023 16:50 AtosGoldman Sachs détient moins de 5% du capital 01/12/2023 16:27 Boeingla Canada va acquérir 16 appareils P-8A Poseidon 01/12/2023 15:41 Johnson & Johnsonle titre profite d'un avis positif d'UBS Tous les articles sociétés |
